In patients with LRRK2 mutations, total aSyn CSF levels were increased in LRRK2-associated PD, non-manifesting carriers, and healthy controls compared to sPD (Vilas et al., 2016). The gene discussed is LRRK2; the disease is Platelet storage pool disease.